neuro42, Inc.
San Francisco, California, United StatesSee on the mapFounded 2020
- Neuroimaging
- Series A
neuro42 develops portable MRI technology for point-of-care neuroimaging and neurosurgical care. Its FDA 510(k)-cleared MRI system is designed for use in settings such as hospital bedsides and clinics, while its interventional MRI platform combines imaging with robotics and AI for MRI-guided surgical procedures.
- Open roles
- 6
- RaisedTotal raised
- $28.8M
- Jul 2021Latest priced round, Jul 2021
- Series A
- Investors
- 7
- Founded
- 2020
reccy insights
neuro42’s most recent identified financing milestone is a $15,551,687 venture round announced on Aug 15, 2024, with Fred Moll, M.D listed as a lead investor. Earlier, the company received a $5 million grant announced on Sep 28, 2023, with the National Institute of Neurological Disorders and Stroke and Fred Moll, M.D identified as leads. Another $485,000 federal grant is dated September 2023, and a further venture financing entry on Oct 5, 2023 does not have an amount specified. These milestones complement the company’s stated work on portable neuroimaging and MRI-guided procedures. Its product positioning includes a portable MRI system described as FDA 510(k)-cleared, as well as an interventional platform combining MRI, robotics, and AI. The available milestones establish financing activity through August 2024, but do not provide later dated announcements, named partnerships, awards, or leadership changes. Accordingly, the company’s recent public profile is clearer on funding and product focus than on subsequent commercial deployments or organizational developments.
Written by reccy's AI from company sites, press and funding records · updated Nov 2026
Open roles6
- Added to reccy 1d ago
Business Development Associate
San Francisco, California · Junior · Added to reccy 1d ago
- Added to reccy 1d ago
Electrical Engineer
San Francisco, California · Mid · Added to reccy 1d ago
- Added to reccy 1d ago
RF Engineer
San Francisco, California · Mid · Added to reccy 1d ago
- Added to reccy 1d ago
Quality & Regulatory Engineer
San Francisco, California · Mid · Added to reccy 1d ago
- Added to reccy 1d ago
Algorithms Engineer
San Francisco, California · Mid · Added to reccy 1d ago
What makes neuro42, Inc. distinct
- 01Portable MRI is designed to extend neuroimaging to bedside, clinic, and other point-of-care settings.
- 02Space-efficient MRI designs aim to fit into surgical environments and support flexible access to imaging.
- 03The interventional platform combines MRI, robotics, and AI for MRI-guided neurosurgical procedures.
- 04The company emphasizes patient-focused design and broader access to advanced neuroimaging.
Technology & products2
- Portable MRI system
FDA 510(k)-cleared MRI system designed for point-of-care neuroimaging in settings such as hospital bedsides and clinics.
- Interventional MRI platform
MRI-guided procedural platform integrating imaging, robotics, and AI for neurosurgical applications.
- Portable FDA 510(k)-cleared MRI system for point-of-care neuroimaging.
- Interventional MRI platform for MRI-guided procedures.
- Precision robotics integrated for neurosurgical applications.
- AI algorithms intended to support real-time surgical decision-making.
Research roots1
Labs and research groups this company came from or works with.
- No page yetMassachusetts General HospitalBoston, United StatesBoston, United States · No page yetLicence
Funding
- Venture RoundAug 2024$15.6MLed by Fred Moll, M.D
- Venture RoundOct 2023Fred Moll, M.D
- GrantSep 2023$5MLed by National Institute of Neurological Disorders and Stroke, Fred Moll, M.D
Investors5
- Fred Moll, M.D
- Zepp Health
- Zepp
Similar companies
About neuro42, Inc.
- Products
- Portable MRI system, Interventional MRI platform
- Leadership
- Michael BartholomewDinesh KumarNikhil SadhwaniAbhita Vohra
- Focus areas
- Medical devices, neuroimaging, MRI, neurosurgery, AI, robotics, point-of-care diagnostics, healthcare
- Headquarters
- San Francisco, California, United States
- Founded
- 2020
- Employees
- 11–50
- Status
- Active · private